Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mind Cure Health Inc (OP: MCURF ) N/A UNCHANGED Last Price Updated: 2:36 PM EDT, Sep 11, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.0340 Today's Range N/A - N/A 52wk Range N/A - N/A Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Cannabis Movers & Shakers: TrueGreen, PSYC, BioSteel Sports Nutrition, Perfect Union, YourWay Cannabis Brands April 12, 2022 Via Benzinga Are Psychedelics Stocks In Trouble Or Is The Market Reaching Maturity? April 04, 2022 Long gone is the heyday of investor enthusiasm and easy access to capital that marked the launch of the psychedelics industry into the public markets. In recent months, psychedelics stocks entered into... Via Benzinga Performance More News Read More Psyched: MindCure Shuts Down Operations, Novamind And MindMed Partner For Study March 22, 2022 Via Benzinga Mind Cure Health Is Shutting Down All Operations, Citing Lack Of Funds To Move Forward March 16, 2022 Via Benzinga InvestorNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Issues Update on Strategic Review March 16, 2022 Via Investor Brand Network Benzinga Expands Footprint into the Psychedelic Industry with the Launch of the Benzinga Psychedelic Advisory Council March 09, 2022 Via Benzinga InvestorNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Marks Key Milestone Within Comprehensive Strategy for Ibogaine Program March 02, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property InvestorNewsBreaks – Mind Cure Health Inc.’s (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Board Forms Special Committee for Strategic Review February 10, 2022 Via Investor Brand Network InvestorNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Appoints Chief Product Officer to Advance iSTRYM Digital Therapeutics Platform February 03, 2022 Via Investor Brand Network BioMedNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH), Announces Participation in Upcoming H.C. Wainwright Bioconnect Conference January 06, 2022 Via Investor Brand Network Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) Inches Closer to iSTRYM’s Commercial Deployment; Announces Dr. Doron Sagman’s Appointment as CMO; and Avails Recent Life Sciences Virtual Conference Presentation for On-Demand Viewing December 30, 2021 Via Investor Brand Network Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) Recognized as One of the Best Women-Led Workplaces, Participates in the December 16 Life Sciences Virtual Investor Conference December 27, 2021 Via Investor Brand Network BioMedNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) Advancing Core Research, Commercial Production Programs, Identifying Pipeline Expansion Opportunities December 20, 2021 Via Investor Brand Network PsychedelicNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Announces Significant Milestone That Brings iSTRYM Closer to Commercial Deployment December 16, 2021 Via Investor Brand Network Exposures Product Safety Why Some Psychedelic Assisted Therapy Clinics Are Turning To Artificial Intelligence for Digital Mental Therapies December 16, 2021 Via FinancialNewsMedia Topics Artificial Intelligence Exposures Artificial Intelligence MINDCURE Announces Certification of HIPAA Compliance, Bringing iSTRYM Closer to Commercial Deployment in the Second Quarter of 2022 December 16, 2021 Via FinancialNewsMedia BioMedNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Announces Strategic CMO Appointment of Dr. Doron Sagman December 14, 2021 Via Investor Brand Network North American Psychedelic Drugs Market Expected To Reach A Value Of $3.184 Billion In 2026 December 14, 2021 Via FinancialNewsMedia MINDCURE Appoints Dr. Doron Sagman as Chief Medical Officer December 14, 2021 Via FinancialNewsMedia Epigenetics, Psychedelics and Stem Cell Therapy are Topics of the Life Sciences Virtual Investor Conference Launching This Thursday December 14, 2021 Via Benzinga Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Discusses Psychedelics Research, Life Sciences Focus, at Key Industry Conferences December 10, 2021 Via Investor Brand Network BioMedNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) Delivering Evidence-Based DTx, Research Centered Around Psychedelics December 08, 2021 Via Investor Brand Network This Company Is Making Synthetic Psychedelics With a Goal To Combat Mental Illness December 08, 2021 Via Benzinga BioMedNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH), Announces Participation in December 2021 Conferences December 03, 2021 Via Investor Brand Network Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Announces Research and Technology Progress, Offers Corporate Update December 03, 2021 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.